INSIGHTS ON CLINICAL TRIAL DESIGN

• BCVA, OCT, And IOP Testing In Clinical Trials

  Are minor inconsistencies in room setup and technician technique quietly compromising your study data? Learn how closing small operational gaps can prevent major downstream risks.

• Balancing Patient Centricity With Complexity In Cancer Trials

  By bringing clinical research closer to where patients live and receive care, sponsors and CROs can expand reach, reduce travel burdens, and engage populations historically underrepresented in cancer studies.

• Human-Centered RTSM Design Enhances Data, Safety, And Operations

  Uncover how this human-centered approach to RTSM prioritizes user experience (UX) and interface design (UI) to reduce complexity, minimize errors, and improve compliance.

• Accelerating Enrollment And Upholding Quality In Complex Oncology Trials

  Real-world oncology trials reveal how fast physician engagement, hands-on biomarker management, and adaptive enrollment shorten timelines, reach first-patient milestones, and preserve data quality.

• The Pharmacy Advantage In Direct-To-Patient Clinical Supply

  3/24/2026

  Understand state pharmacy regulations, prescription requirements, and operational considerations for shipping clinical supplies directly from pharmacies to patients' homes in decentralized trial models.

• Phase I Clinical Trial Designs: Continuous Reassessment Method (CRM)

  9/25/2025

  The benefits are clear: CRM accelerates dose finding, reduces patient exposure to unsafe doses, and improves trial efficiency.

• Critical Imaging Risks In GLP-1 And Neurology Studies

  5/27/2025

  As imaging grows in importance within GLP-1 and neurology trials, it must be treated not as a routine task but as a strategic pillar that supports participant safety and reproducible outcomes.

• How Pharmaceutical Companies Can Effectively Engage With PAOs

  2/11/2025

  Experts explain the role of Patient Advocacy Organizations (PAOs), tips for pharmaceutical companies and PAOs to forge strong relationships, and techniques to integrate patient perspectives.

• Clinical Trial Access In The U.S.: Where Are Today's Trials Missing?

  7/9/2024

  Access to clinical trials in the U.S. is uneven, leaving many regions underserved. Let's examine site distribution, the impact of healthcare deserts, and ways to improve trial accessibility for all Americans.